TODAY
TODAY
TODAY

On Wednesday, 17 June, the government announced that all civil servants will received a special one-off SG50 bonus of S$500. This is to mark the nation’s 50th jubilee year as an independent state.

This is in addition to the previously announced 0.5 month mid-year Annual Variable Component (AVC) payment the civil servants will receive in July.

The Public Service Division (PSD) said that the one-off SG50 bonus is “in recognition of their contribution towards nation-building”.

There are an estimated 82,000 civil servants in the Public Service, out of about 140,000 public servants.

The bonus, while welcome by those who will benefit from it, nonetheless was questioned by some who asked why only civil servants were given this special recognition.

Why, they ask, are public servants not similarly rewarded?

Some, like Mr Sim Ghee Choon, asks for such a bonus to be extended to all Singaporeans through their CPF accounts.

“[It] is disheartening that Singaporeans who work in the private sector will miss out on this jubilee celebration,” Mr Sim wrote in his letter to the Straits Times forum page on Friday.

“Stay-at-home mothers who are taking care of the next generation and retirees will also not be similarly rewarded,” he added.

He asks if the Government would consider giving this bonus to all citizens in their Central Provident Fund accounts instead.

Others, more skeptical, wonder if the sudden bonus is geared towards “softening” the ground ahead of an expected general election in the months ahead. (See here.)

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

Advisory council proposes further liberalisations of the Internet

AIMs seeks feedback on Internet regulation. Report by Gerald Giam.

新加坡与国际机构紧密合作 研发新疫苗对付新冠

杜克-NUS医学院传染病研究主任王林发称,新加坡正与国际机构流行病防范创新联盟(CEPI)密切合作,研发对付新冠病毒疫苗。 上周,CEPI召集各地专家,尽快开发和研制新疫苗以对抗新冠病毒。而到了本周将会挑选出适合的团队,并给予至少16周的时间来接种疫苗,随后再决定是否准备好进入第一阶段的临床试验。 王林发在记者会上指出,“我们正试图说服他们在新加坡进行第一阶段的临床试验。” 尽管加快速度研发疫苗,但专门研究传染病的许立阳副教授表示,在研发疫苗上可能会需要更多时间,至少需要一年的时间准备疫苗上市。 “这是因为疫苗的研发需要经过安全有效的监控,即使在此次疫情爆发后,最后能够如愿达到很好的控制,但仍然非常感恩能够研发有效疫苗,以应对未来再度爆发”,他表示。 自疫情爆发以来,新加坡已出现45例确诊病例,成为中国以外,续日本后确诊病例最多的国家。 赖建文:部分患者使用HIV药物迅速现反应,但也有持续恶化的现象 此外,《亚洲新闻台》报道,参与临床研究的陈笃生医院国家传染病中心传染病研究与培训部主任赖建文指出,在对抗病毒时,会给予部分患者使用人类免疫缺陷病毒(HIV)的药物。 他解释,当这些患者使用HIV药物时,医生也会观察他们的氧气水平是否提高,发烧症状是否减退,以及他们的拭子是否对新冠病毒呈阴性。 “由于使用的患者人数较少,而且其他的国家使用的样本数也较少,加上没有详细的数据,很难确定其效用,但在我们的经验中,能够在部分患者看到非常迅速的效应。同时我们也看到有些人持续恶化的现象。” 他续指,专家目前正积极研究开发,同时也正讨论研究方案,其研究方案应包含何种患者;是否应对无任何症状的呈阳性结果的患者给予含有副作用的潜在药物;药物的种类等等,也在其争议之中。 他补充道,目前有种药物对于中东呼吸综合征冠状病毒(MERS-CoV)以及新型冠状病毒具有“良好的活性”,并曾用于动物以及测试埃博拉(Ebola)病毒的实验中,但它尚未适用于治疗新型冠状病毒。…

A letter to Mr Sitoh Yihpin

Sophia Tsang / First my congratulations at winning the recent elections. It…

Criminal Lawyers call on Law Ministry to abolish the Death Penalty and Decriminalize 377A and Euthanasia

During an interview with the Straits Times in December 2014, the late…